Charles River announced the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based contract service organization that provides safety and quality control services to biopharmaceutical clients. NewLab has approximately 150 employees. Both Charles River and ... mehr
Charles River Acquires NewLab BioQuality AG
Charles River announced the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based contract service organization that provides safety and quality control services to biopharmaceutical clients. NewLab has approximately 150 employees.
Both Charles River and NewLab provide analytical, molecular biology, virology and microbiology testing services to ensure identity, quality, stability and safety of biopharmaceuticals, and operate in full compliance with current GMP/GLP (Good Laboratory Practice) regulatory guidance. Together, Charles River and NewLab expect to provide the most comprehensive service package in the biopharmaceutical industry at a time when biologic drugs are becoming an increasing proportion of therapeutics in development.
With current operations in the United States, Scotland and Ireland, the transaction will expand Charles River's current biopharmaceutical services footprint by adding two facilities in continental Europe and will further enhance its European and Asian client base.
- Charles River
- NewLab BioQuality
- Gute Laborpraxis
Mit Wirkung zum 01. August 2005 hat die NewLab BioQuality AG (NewLab) 100% der Anteile der Firma Analysis Biomedizinische Test GmbH, Köln (Analysis) einschließlich des gesamten Personals übernommen. Der NewLab-Geschäftsbereich Virologie wird damit um wertvolle Kompetenzen und Erfahrungen er ... mehr
Die Protagen AG und Charles River Laboratories International Inc. sind eine strategische Partnerschaft eingegangen, um gemeinsam analytische Dienstleistungen von der Zelllinienentwicklung bis hin zur Batchfreigabe von Biopharmazeutika anbieten zu können. Im Rahmen des zunächst auf zwei Jahr ... mehr
Virtual screening (VS) is an established computational approach that employs knowledge to select potentially bioactive compounds for screening. Both structure-based and ligand-based VS is typically applied to large virtual chemical collections to shortlist compounds that have a better chanc ... mehrWebinarOn-Demand
Endotoxin testing continues to be an evolving field. Recently, concerns have arisen that endotoxin might not be detected with the LAL assay in many biologics. As part of the continuing conversation around this issue, the webinar discusses: Composition of plasma and endotoxin limits ... mehrWebinarOn-Demand
Rodent models have long played a key role in understanding multiple sclerosis (MS) and in developing therapies that effectively target the disease. With a focus on models that reflect the inflammation and demyelination process, this webinar examines those most useful in MS research and how ... mehr